Literature DB >> 8353172

THA does not affect sleep or EEG spectral power in Alzheimer's disease.

D Petit1, J Montplaisir, D Lorrain, S Gauthier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8353172     DOI： 10.1016/0006-3223(93)90128-z

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  5 in total

Review 1.  Pharmacotherapies for sleep disturbances in dementia.

Authors:  Jenny McCleery; Daniel A Cohen; Ann L Sharpley
Journal:  Cochrane Database Syst Rev       Date:  2016-11-16

Review 2.  Sleep disturbances in patients with Alzheimer's disease: epidemiology, pathophysiology and treatment.

Authors:  M V Vitiello; S Borson
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 3.  Galanthamine.

Authors:  B Fulton; P Benfield
Journal:  Drugs Aging       Date:  1996-07       Impact factor: 3.923

Review 4.  Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease.

Authors:  A J Wagstaff; D McTavish
Journal:  Drugs Aging       Date:  1994-06       Impact factor: 3.923

5.  Pharmacotherapies for sleep disturbances in dementia.

Authors:  Jenny McCleery; Ann L Sharpley
Journal:  Cochrane Database Syst Rev       Date:  2020-11-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.